Search results for " Gut microbiome"

showing 7 items of 7 documents

Relevance of secretor status genotype and microbiota composition in susceptibility to rotavirus and norovirus infections in humans

2017

Host genetic factors, such as histo-blood group antigens (HBGAs), are associated with susceptibility to norovirus (NoV) and rotavirus (RV) infections. Recent advances point to the gut microbiome as a key player necessary for a viral pathogen to cause infection. In vitro NoV attachment to host cells and resulting infections have been linked to interactions with certain bacterial types in the gut microbiota. We investigated the relationship between host genotype, gut microbiota, and viral infections. Saliva and fecal samples from 35 adult volunteers were analysed for secretor status genotype, the gut microbiota composition by 16S rRNA gene sequencing, and salivary IgA titers to NoV and RV. Hi…

0301 basic medicineAdultMaleSalivaGenotype030106 microbiologyResistanceMicrobiologiaGut floraHuman gut microbiomemedicine.disease_causeArticleRotavirus InfectionsMicrobiologyAssociation03 medical and health sciencesFecesfluids and secretionsBlood group antigensFut2 geneRotavirusGenotypemedicineHumansGenetic Predisposition to DiseaseDiseaseMicrobiomePolymorphismSalivaPathogenEcosystemCaliciviridae InfectionsMultidisciplinaryEnteric bacteriabiologyRuminococcusMiddle Agedbiology.organism_classificationFucosyltransferasesVirusGastrointestinal MicrobiomeGastroenteritis030104 developmental biologyImmunologyNorovirusFemale
researchProduct

Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection

2016

C. difficile is a major enteric pathogen with worldwide distribution. Its expansion is associated with broad-spectrum antibiotics which disturb the normal gut microbiome. In this study, the DNA sequencing of highly active bacteria and bacteria opsonized by intestinal secretory immunoglobulin A (SIgA) separated from the whole bacterial community by FACS elucidated how the gut dysbiosis promotes C. difficile infection (CDI). Bacterial groups with inhibitory effects on C. difficile growth, such as Lactobacillales, were mostly inactive in the CDI patients. C. difficile was typical for the bacterial fraction opsonized by SIgA in patients with CDI, while Fusobacterium was characteristic for the S…

0301 basic medicineClostridium Cluster IVmedicine.drug_class030106 microbiologyAntibioticslcsh:QR1-502Microbiologylcsh:MicrobiologyantibioticsMicrobiologyHost-Microbe Biology03 medical and health sciencesClostridium difficile infectionmedicineMicrobiomeMolecular Biology16S rRNA gene sequencinghuman gut microbiomebiologyLactobacillalesdysbiosisClostridium difficilebiology.organism_classificationmedicine.diseaseQR1-502030104 developmental biologyBayesian networksFusobacteriumImmunologysecretory immunoglobulin ADysbiosisBacteriafluorescence-activated cell sortingResearch ArticlemSphere
researchProduct

The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties.

2020

The emergence of superbugs developing resistance to antibiotics and the resurgence of microbial infections have led scientists to start an antimicrobial arms race. In this context, we have previously identified an active RiPP, the Ruminococcin C1, naturally produced by Ruminococcus gnavus E1, a symbiont of the healthy human intestinal microbiota. This RiPP, subclassified as a sactipeptide, requires the host digestive system to become active against pathogenic Clostridia and multidrug-resistant strains. Here, we report its unique compact structure on the basis of four intramolecular thioether bridges introduced post-translationally by a specific radical-SAM sactisynthase. This structure con…

0301 basic medicinemedicine.drug_class[CHIM.THER] Chemical Sciences/Medicinal ChemistryAntibioticsgut microbiomeContext (language use)Peptide[CHIM.THER]Chemical Sciences/Medicinal Chemistry010402 general chemistry01 natural sciencesMicrobiologyClostridia03 medical and health sciencesRuminococcus gnavusantibioticmedicineRiPPHumansIntestinal Mucosa[SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitologychemistry.chemical_classificationRadical SAM enzymeClostridialesMultidisciplinarybiologyRiPPs Ruminococcin C sactipeptide gut microbiome antibiotic[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyBacterial InfectionsBiological Sciencesbiology.organism_classificationAntimicrobialIntestinal epithelium[SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology0104 chemical sciences3. Good healthsactipeptideAnti-Bacterial AgentsRuminococcus gnavusRiPPs030104 developmental biology[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologychemistryRuminococcin CPeptidesBacteriaProceedings of the National Academy of Sciences of the United States of America
researchProduct

Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial

2022

Abstract Background Human milk oligosaccharides (HMOs) have important and diverse biological functions in early life. This study tested the safety and efficacy of a starter infant formula containing Limosilactobacillus (L.) reuteri DSM 17938 and supplemented with 2’-fucosyllactose (2’FL). Methods Healthy infants < 14 days old (n = 289) were randomly assigned to a bovine milk-based formula containing L. reuteri DSM 17938 at 1 × 107 CFU/g (control group; CG) or the same formula with added 1.0 g/L 2’FL (experimental group; EG) until 6 months of age. A non-randomized breastfed group served as reference (BF; n = 60). The primary endpoint was weight gain through 4 months of age in the formula-…

Gut microbiomeNutrition and DieteticsMilk HumanProbioticsgrowthHuman milk oligosaccharidesMedicine (miscellaneous)InfantOligosaccharidesgut microbiomeinfant formulaGrowth2’fucosyllactose2’fucosyllactose Growth Gut microbiome Human milk oligosaccharides Infant formula2'fucosyllactoseFecesDouble-Blind MethodInfant formulaHumansPediatrics Perinatology and Child HealthTrisaccharidesPhylogeny
researchProduct

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function.

2022

Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into …

Intestins--MicrobiologiaMicrobiologiaPathogenesisBlastocystis InfectionsMicrobiologyMETAGENOMICSMEMBERExecutive FunctionMicegut microbiota ; Blastocystis ; executive function ; gut microbiome-brain axis.CognitionAparell digestiuDiagnosisAnimalsHumansEcology Evolution Behavior and SystematicsBlastocistMEMORYDNAGastrointestinal MicrobiomeCognicióBlastocystisBlastocist -- InfeccióMicrobiomaBiomarkersThe ISME journal
researchProduct

New insights into the gut microbiome in loggerhead sea turtles Caretta caretta stranded on the Mediterranean coast

2019

Caretta caretta is the most common sea turtle species in the Mediterranean Sea. The species is threatened by anthropomorphic activity that causes thousands of deaths and hundreds of strandings along the Mediterranean coast. Stranded turtles are often cared for in rehabilitation centres until they recover or die. The objective of this study was to characterize the gut microbiome of nine sea turtles stranded along the Sicilian coast of the Mediterranean Sea using high-throughput sequencing analysis targeting V3–V4 regions of the bacterial 16S rRNA gene. Stool samples were collected from eight specimens hosted in the recovery centre after a few days of hospitalization (under 7) and from one ho…

Mediterranean climateDIVERSITYSettore BIO/05 - ZoologiamicrobiomePathology and Laboratory MedicineSettore BIO/19 - Microbiologia GeneraleDatabase and Informatics MethodsMediterranean seacaretta carettaRNA Ribosomal 16SOceansMedicine and Health Sciencesbacteria0303 health sciencesMultidisciplinarybiologyDEBRIS INGESTIONQREukaryotaGenomicsTurtlesBacterial PathogensSea turtleMedical MicrobiologyVertebratesMedicinegutBACTERIAL COMMUNITIESPathogensProteobacteriaSequence AnalysisResearch ArticleBioinformaticsFirmicutesScienceSequence DatabasesFirmicutesmediterraneanZoologyMicrobial GenomicsResearch and Analysis MethodsMicrobiologyFusobacteriaDIET03 medical and health sciencesBodies of waterProteobacterialoggerheadGeneticsMediterranean SeaAnimalsMicrobiomeMicrobial Pathogens030304 developmental biologyBacteroidetes030306 microbiologyGut BacteriaOrganismsBiology and Life SciencesReptilesBacteroidetesbiology.organism_classificationEVOLUTIONMarine and aquatic sciencesGastrointestinal MicrobiomeEarth sciencesBiological DatabasesTestudinesAmniotesThreatened speciesCaretta caretta gut microbiome sea turtles Mediterranean Sea
researchProduct

Adaptation of the Human Gut Microbiota Metabolic Network During the First Year After Birth

2019

Predicting the metabolic behavior of the human gut microbiota in different contexts is one of the most promising areas of constraint-based modeling. Recently, we presented a supra-organismal approach to build context-specific metabolic networks of bacterial communities using functional and taxonomic assignments of meta-omics data. In this work, this algorithm is applied to elucidate the metabolic changes induced over the first year after birth in the gut microbiota of a cohort of Spanish infants. We used metagenomics data of fecal samples and nutritional data of 13 infants at five time points. The resulting networks for each time point were analyzed, finding significant alterations once sol…

Microbiology (medical)lcsh:QR1-502Metabolic networkComputational biologyBiologyGut floradigestive systemMicrobiologylcsh:Microbiology03 medical and health sciencesMetabolomicsHuman gutpersonalized nutritionFecesOriginal Research030304 developmental biologyhuman gut microbiomemetagenomics0303 health sciences030306 microbiologyExperimental validationbiology.organism_classificationmetabolomicsMetagenomicsmetabolic networksAdaptation
researchProduct